176 Days Left

i4i Product Development Awards (PDA)

Fund Name

i4i Product Development Awards (PDA)

Project Length

Up to 36 months

Project Value

No max

Deadline

06.12.2023

The i4i Product Development Awards (PDA) support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in health or social care systems. PDA is researcher-led and aims to de-risk innovations to make them more attractive for follow-on funding and investment in the next stage of development.

Check Your Eligibility

Fund details

PDA is researcher-led and aims to de-risk innovations to make them more attractive for follow-on funding and investment in the next stage of development. The expected focus of a PDA is to carry out product development required to enable a technology for clinical use or use in social care, and/or the clinical development of a laboratory-validated technology.

Projects must have a clear pathway towards adoption and commercialisation.

Proposals must involve one of the following:

PDA will fund the preclinical and clinical development of innovative technologies, gathering the required evidence for regulatory approvals and follow-on studies.

Projects must have demonstrated proof-of-concept as a minimum, which is generally described as TRL3. As part of demonstrating proof-of-concept, applicants are expected to have already generated experimental data to support the case for further development and illustrate technical feasibility or have concluded a robust review of existing literature. A strong element of patient and public involvement and end-user engagement is a prerequisite for PDA.

Proposals must also set out a commercial strategy that takes into account the regulatory pathway, IP management, commercial barriers, health economics and route to market. A plan for future adoption of the technology into the NHS or social care system should be presented.

Applicants should be aware of the NHS MedTech Funding Mandate policy, which came into effect in April 2021 to help overcome the financial barriers to adopting medical devices, diagnostics and digital products in the NHS, as well as other government policies as updated.

Eligibility

  • Projects may last up to 3 years,
  • SMEs and NHS organisations may receive up to 100% of the requested funding, with no requirement for matched funding for commercial organisations
  • Higher Education Institutions are entitled to up to 80% of the full economic costs (please refer to the Finance guidance for more details)
  • Entry point: Experimental proof-of-concept or laboratory-validated technology
  • The maximum number of co-applicants is two
  • No maximum funding level but the typical budget ranges from £0.5-£1.5m
Contact us